First Trust Nasdaq Pharmaceuticals ETF (FTXH) Stock Forecast
Alert
Its only available to paid users.
N/A
Based on the First Trust Nasdaq Pharmaceuticals ETF stock forecast from 0 analysts, the average analyst target price for First Trust Nasdaq Pharmaceuticals ETF is not available over the next 12 months. First Trust Nasdaq Pharmaceuticals ETF’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of First Trust Nasdaq Pharmaceuticals ETF is Slightly Bullish , which is based on 4 positive signals and 2 negative signals. At the last closing, First Trust Nasdaq Pharmaceuticals ETF’s stock price was USD 27.99. First Trust Nasdaq Pharmaceuticals ETF’s stock price has changed by +2.66% over the past week, +3.53% over the past month and -0.13% over the last year.
Analyst Ratings
Target Price Action
Rating Action
Analyst
Rating
Price
Date
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Superior total returns
The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.
High dividend returns
The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.
What not to like
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Add to Watchlists
loading..
Download Confirmation
Premium customers can only download records visible on the current page view, while Platinum customers can download the first 1000 records.
Paid-only feature
CSV downloads are only available for paying customers.
Thank you for Sharing your Stock Targets for FTXH !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
